Notes:
Page 33
Volume 05
Journal of Clinical Nutrition & Dietetics
ISSN: 2472-1921
JOINT EVENT
June 17-18, 2019 London, UK
Nutrition World 2019
Euro Obesity 2019
June 17-18, 2019
&
26
th
World Nutrition Congress
15
th
Euro Obesity and Endocrinology Congress
Conclusion and Significance
: On 26
th
week of liraglutide 3.0 mg treatment, there is a statistically significant weight
and fat mass loss. On the other hand, there is also some fat-free mass and skeletal muscle mass loss. Therefore,
would be advisable to preserve these values.
Finally, this study shows relevant results in order to optimize weight loss programs in obesity cases.
Biography
Monica Dearos Sanchis is a graduate in human nutrition and dietetics at the University of Valencia (Spain). He has a master's degree in personalized nutrition
and is currently doing his doctorate in the line of endocrinology and nutrition at the General Hospital of Valencia. He also works in a private clinic in the field of
obesity.
mdsanchis@hotmail.com